Woitalla D - Search Results

1

Genetic analysis of immunomodulating factors in sporadic Parkinson's disease.

Krüger R, Hardt C, Tschentscher F, Jäckel S, Kuhn W, Müller T, Werner J, Woitalla D, Berg D, Kühnl N, Fuchs GA, Santos EJ, Przuntek H, Epplen JT, Schöls L, Riess O. Krüger R, et al. Among authors: woitalla d. J Neural Transm (Vienna). 2000;107(5):553-62. doi: 10.1007/s007020070078. J Neural Transm (Vienna). 2000. PMID: 11072751

2

Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, Kösel S, Przuntek H, Epplen JT, Schöls L, Riess O. Krüger R, et al. Among authors: woitalla d. Nat Genet. 1998 Feb;18(2):106-8. doi: 10.1038/ng0298-106. Nat Genet. 1998. PMID: 9462735 No abstract available.

3

High prevalence of parkinsonism after occupational exposure to lead-sulfate batteries.

Kuhn W, Winkel R, Woitalla D, Meves S, Przuntek H, Müller T. Kuhn W, et al. Among authors: woitalla d. Neurology. 1998 Jun;50(6):1885-6. doi: 10.1212/wnl.50.6.1885. Neurology. 1998. PMID: 9633752

4

Plasma levels of R- and S-salsolinol are not increased in "de-novo" Parkinsonian patients.

Müller T, Sällström Baum S, Häussermann P, Woitalla D, Rommelspacher H, Przuntek H, Kuhn W. Müller T, et al. Among authors: woitalla d. J Neural Transm (Vienna). 1998;105(2-3):239-46. doi: 10.1007/s007020050052. J Neural Transm (Vienna). 1998. PMID: 9660101 Clinical Trial.

5

Tolcapone and neurotoxicity in Parkinson's disease.

Kuhn W, Woitalla D, Gerlach M, Russ H, Müller T. Kuhn W, et al. Among authors: woitalla d. Lancet. 1998 Oct 17;352(9136):1313-4. doi: 10.1016/S0140-6736(05)70527-4. Lancet. 1998. PMID: 9788488 No abstract available.

6

Elevated plasma levels of homocysteine in Parkinson's disease.

Kuhn W, Roebroek R, Blom H, van Oppenraaij D, Przuntek H, Kretschmer A, Büttner T, Woitalla D, Müller T. Kuhn W, et al. Among authors: woitalla d. Eur Neurol. 1998 Nov;40(4):225-7. doi: 10.1159/000007984. Eur Neurol. 1998. PMID: 9813406

7

Analysis of the parkin deletion in sporadic and familial Parkinson's disease. Short communication.

Krüger R, Vieira-Säcker AM, Kuhn W, Müller T, Woitalla D, Schöls L, Przuntek H, Epplen JT, Riess O. Krüger R, et al. Among authors: woitalla d. J Neural Transm (Vienna). 1999;106(2):159-63. doi: 10.1007/s007020050148. J Neural Transm (Vienna). 1999. PMID: 10226936

8

Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype.

Krüger R, Vieira-Saecker AM, Kuhn W, Berg D, Müller T, Kühnl N, Fuchs GA, Storch A, Hungs M, Woitalla D, Przuntek H, Epplen JT, Schöls L, Riess O. Krüger R, et al. Among authors: woitalla d. Ann Neurol. 1999 May;45(5):611-7. doi: 10.1002/1531-8249(199905)45:5<611::aid-ana9>3.0.co;2-x. Ann Neurol. 1999. PMID: 10319883

9

Detection of tolcapone in the cerebrospinal fluid of parkinsonian subjects.

Russ H, Müller T, Woitalla D, Rahbar A, Hahn J, Kuhn W. Russ H, et al. Among authors: woitalla d. Naunyn Schmiedebergs Arch Pharmacol. 1999 Dec;360(6):719-20. doi: 10.1007/s002109900168. Naunyn Schmiedebergs Arch Pharmacol. 1999. PMID: 10619191 Clinical Trial.

10

The activity of catechol-O-methyltransferase in parkinsonian patients with "on-off fluctuations".

Woitalla D, Karwasz R, Müller T, Przuntek H, Kuhn W. Woitalla D, et al. J Neural Transm (Vienna). 2000;107(1):105-11. doi: 10.1007/s007020050009. J Neural Transm (Vienna). 2000. PMID: 10809408

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

133 results

Search Page

Filters